Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trialsNish Chaturvedi, Anne Katrin Sjølie, Trevor J. Orchard et al.|The Lancet|2008Cited by 450
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trialAnne Katrin Sjølie, Nish Chaturvedi, Trevor J. Orchard et al.|The Lancet|2008Cited by 432
Retinopathy and Vision Loss in Insulin-dependent Diabetes in EuropeAnne Katrin Sjølie, J. Nunes-Cornea, Mauro Cignarelli et al.|Ophthalmology|1997Cited by 217
Diabetic Retinopathy Is Associated With Mortality and Cardiovascular Disease IncidenceManon V. van Hecke, Nish Chaturvedi, A. Kofinis et al.|Diabetes Care|2005Cited by 180